Cellulite Treatment with Cellulaze™
It can be one of the most frustrating developments in the appearance of our skin, and unfortunately, it affects women the most: cellulite. About 85 percent of women over the age of 20 have cellulite, a condition which causes a dimpling or depressed appearance in the skin, usually affecting the thighs, buttocks, or abdominal region. Dr. Christine Petti is a female plastic surgeon who understands how cellulite can have a significant impact on how we view our bodies.
Please contact our practice for more information on cellulite treatment, including the new, FDA-approved Cellulaze™ procedure.
Watch Dr. Petti Banish Cellulite on “The Doctors”
The video below features Dr. Petti’s appearance on “The Doctors” television program as she discusses banishing cellulite with the Cellulaze treatment. Cellulaze is the first cellulite treatment approved by the FDA and shown to reduce cellulite for a year or longer with one treatment.
Causes of Cellulite
Cellulite is the appearance of dimples or depressions on the skin that typically occur in body areas such as the buttocks, thighs, or hips. Because of differences in the way a woman’s body distributes fat, connective tissue, and muscle, cellulite is more common in women than in men. Cellulite often appears lumpy because pockets of fat are pushing the connective tissues underneath the skin, ultimately causing imperfections in the skin’s surface. Common causes of cellulite include:
- The natural aging process
- Thickness of the skin
- How your body distributes fat
Cellulite is an extraordinarily common condition that affects a huge majority of women. Although there have been limited options for treatment thus far that may be changing.
Cellulaze™ by Cynosure®
Ladies, the dimples and bumps and cottage cheese-like appearance that cellulite often causes on the skin may soon become a thing of the past with a new treatment recently approved by the FDA. It’s called Cellulaze™, and Dr. Christine Petti was chosen as part of an elite team of clinical investigators who spent two years looking into its effectiveness. The results of the study found that, after one year, patients experienced a 25% increase in skin thickness, 29% showed an increase in skin elasticity, and an astounding 93% were satisfied with Cellulaze™ treatment – even after an entire year!
Video: How Cellulaze™ Works
Although cellulite is often difficult to treat, Cynosure®, the developers of the Smartlipo™ Laser, just received FDA-approval for a new cellulite treatment called Cellulaze™, a state-of-the-art laser procedure that has been shown to reduce cellulite for a year or longer.
Dr. Petti Presents on Cellulaze™for Cynosure University Webinar
On May 28, 2020 Dr. Petti was the featured laser expert and host of Cynosure University’s Body Contouring Global Webinar. In addition to Cellulaze™, Dr. Petti discusses energy-based body contouring technologies including Smartlipo® laser liposuction for body sculpting, as well as WarmSculpting™ 25-minute nonsurgical fat reduction with SculpSure®:
The Cellulaze™ Procedure
Up to now, the battle to treat that dreaded word, “cellulite,” has often been a losing one. Lotions, massages, and temporary fixes have simply not been very effective in fighting an affliction that more than 85% of all women face, a condition that is completely beyond a person’s control.
Cellulaze™ goes after the root cause of cellulite, attacking cellulite’s structure and diminishing the appearance of dimples, bumps, and bulges. It is a one-time treatment with results that can last up to a year. Dr. Petti performs Cellulaze™ treatment by using a 3-D fiber optic laser inserted through tiny incisions (about the size of the tip of a ballpoint pen) in the target areas. The ultra-thin laser will then be used to level out bumps, release fibrous bands under the skin that cause dimpling, and help to stimulate the growth of collagen for smoother skin in the area. Liquefied fat will be pushed out.
The entire Cellulaze™ procedure typically takes about one to one and-a-half hours to complete and is performed with localized anesthesia applied to the areas targeted for treatment. Plus, there is usually no downtime necessary after treatment with Cellulaze™ – most patients can resume normal daily activities immediately after the procedure.
What to Expect after Cellulaze™ Treatment
Although there will be some bruising in the treatment areas after the procedure, this should fade over the next few days. Results from Cellulaze™ will continue to improve for the next three months to one year.
Cellulaze™ is the first treatment for cellulite approved by the U.S. Food and Drug Administration that attacks the problem at its very source – inside the skin. Dr. Christine Petti is very proud to have been part of the investigative team that conducted clinical studies on Cellulaze™ and helped make it available to millions of women.
With Cellulaze™, you can significantly reduce the appearance of cellulite with long-lasting results!
What Patients are Saying About Cellulaze™
I felt very comfortable with the anesthesiologist. He was patient, personable and very pleasant. I felt the same way with the nurses. Dr. Petti Was amazing, it felt like I was talking with my sister! And I have complete confidence in her and her staff! A++
KS – Los Angeles
Dear Dr. Petti,
Thank you so much for being the wonderful, caring doctor, surgeon, and woman that you are. I feel privileged to be part of your Cellulaze™ study and to take part in “The Doctors” experience. If took me a while to build the nerve for me to watch the show – but I’m really impressed by how tastefully it was done. But the best part of the experience was spending the day with you. I hope you find a way to successfully balance all the demands in your life and get to that “zen” state of mind. And when you find the answer, let me know!
Lots of Love,
M – Los Angeles
Schedule a Consultation for Cellulaze™ Treatment
If you would like more information on Cellulaze™, or if you would like to schedule a consultation with Dr. Petti to discuss all aspects of the procedure, please contact us today.